Cargando…
Correction for Chia et al., Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191772/ https://www.ncbi.nlm.nih.gov/pubmed/35658084 http://dx.doi.org/10.1073/pnas.2206754119 |
Ejemplares similares
-
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
por: Chia, Ruth, et al.
Publicado: (2022) -
Correction to: Eculizumab: A Review in Generalized Myasthenia Gravis
por: Dhillon, Sohita
Publicado: (2018) -
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019) -
Correction to: Burden of disease in myasthenia gravis: taking the patient’s perspective
por: Lehnerer, Sophie, et al.
Publicado: (2022) -
Correction to: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use
por: Heo, Young-A
Publicado: (2023)